alverine
Small moleculeexperimental
Alverine is a drug used for functional gastrointestinal disorders. Alverine is a smooth muscle relaxant. Smooth muscle is a type of muscle that is not under voluntary control; it is the muscle present in places such as the gut and uterus. — Wikipedia
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
1
Earliest trial started Sep 3, 2018 (NCT04145856)
Timeline
No events for the selected filters.
Indications
Approved for
Studied for
Mechanism of action
- L-type calcium channelINHIBITOR
L-type calcium channel inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaAlverine ↗
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05100719 | N/A | Sep 30, 2022 | University of Pecs |
| NCT04145856 | Phase 4 | Sep 3, 2018 | Hospital Juarez de Mexico |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Hospital Juarez de Mexico | Academic/Hospital | 1 | 1 | 1 | 2018 |
| University of Pecs | Academic/Hospital | 1 | 1 | 1 | 2022 |
2 organizations
Page 1 / 1